Adaptive Biotechnologies

• Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

  Collaborator, Phase 2, Recruiting, 30 people, 12 Feb 2024

• NCT04419519

  Collaborator, Phase 2, Active, not recruiting, 81 people, 5 Jun 2020

Sources: clinicaltrials.gov

• Age as a moderator of neurocognitive performance in patients with large B-cell lymphoma treated with axicabtagene ciloleucel

  Consulting or advice, Fees or honoraria, 8 Sept 2026

• Single-cell, multi-region profiling of the macaque brain across the lifespan

  Consulting or advice, Founder, Board or leadership role, 1 Nov 2025

Sources: pubmed.ncbi.nlm.nih.gov